Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E

Archives of Virology

Volumn 143, Issue 1, 1998, Pages 157-162

  Inoshima, Y ^a   Miyazawa, T ^a   Kohmoto, M ^a   Ikeda, Y ^a   Sato, E ^a   Hohdatsu, T ^b   Mathiason Dubard, C ^c   Hoover, E A ^c   Mikami, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANIMAL; ARTICLE; BLOOD; CAT; CAT DISEASE; CLASSIFICATION; CROSS REACTION; FELINE IMMUNODEFICIENCY VIRUS; GENETICS; GENOTYPE; IMMUNOLOGY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, VIRAL; CATS; CROSS REACTIONS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENOTYPE; IMMUNODEFICIENCY VIRUS, FELINE; NEUTRALIZATION TESTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; RNA VIRUSES;

EID: 0031885071     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050275     Document Type: Article

References (30)

1. De Ronde A, Stam JG, Boers P, Langedijk H, Meloen R, Hesselink W, Keldermans LCEJM, Van Vliet A, Verschoor EJ, Horzinek MC, Egberink HF (1994) Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198: 257-264
2. Diehl LJ, Mathiason-Dubard CK, O'Neil LL, Hoover EA (1996) Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection. J Virol 70: 2503-2507
3. Flynn JN, Beatty JA, Cannon CA, Stephens EB, Hosie MJ, Neil JC, Jarrett O (1995) Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res Hum Retroviruses 11:1 107-1 113
4. Flynn JN, Keating P, Hosie MJ, Mackett M, Stephens EB, Beatty JA, Neil JC, Jarrett O (1996) Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J Virol 157: 3 658-3 665
5. Hohdatsu T, Pu R, Torres BA, Trujillo S, Gardner MB, Yamamoto JK (1993) Passive antibody protection of cats against feline immunodeficiency virus infection. J Virol 67: 2 344-2 348
6. Hohdatsu T, Fujimori S, Maeki M, Suma N, Motokawa K, Okada S, Koyama H (1997) Virus neutralizing antibody titer to feline immunodeficiency virus isolates of subtypes A, B and D in experimentally or naturally infected cats. J Vet Med Sci 59: 377-381
7. Hosie MJ, Osborne R, Yamamoto JK, Neil JC, Jarrett O (1995) Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol 69: 1 253-1 255
8. Hosie MJ, Flynn JN (1996) Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J Virol 70: 7561-7568
9. Inada G, Miyazawa T, Inoshima Y, Kohmoto M, Ikeda Y, Liu C-H, Lin JA, Kuo T-F, Mikami T (1997) Phylogenetic analysis of feline immunodeficiency virus isolated from cats in Taiwan. Arch Virol 142: 1 459-1 467
10. Inoshima Y, Ikeda Y, Kohmoto M, Pecoraro MR, Shimojima M, Shimojima Y, Inada G, Kawaguchi Y, Tomonaga K, Miyazawa T, Mikami T (1996) Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus. J Vet Med Sci 58: 925-927
11. Johnson CM, Torres BA, Koyama H, Yamamoto JK (1994) FIV as a model for AIDS vaccination. AIDS Res Hum Retroviruses 10: 225-228
12. Kakinuma S, Motokawa K, Hohdatsu T, Yamamoto JK, Koyama H, Hashimoto H (1995) Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J Virol 69: 3 639-3 646
13. Kostrikis LG, Cao Y, Ngai H, Moore JP, Ho DD (1996) Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol 70: 445-458
14. Lombardi S, Garzelli C, Rosa CL, Zaccaro L, Spencer S, Malvaldi G, Tozzini F, Esposito F, Bendinelli M (1993) Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J Virol 67: 4742-4749
15. Maki N, Miyazawa T, Fukasawa M, Hasegawa A, Hay ami M, Miki K, Mikami T (1992) Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch Virol 123: 29-45
16. Matteucci D, Pistello M, Mazzetti P, Giannecchini S, Del Mauro D, Zaccaro L, Bandecchi P, Tozzini F, Bendinelli M (1996) Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J Virol 70: 617-622
17. Miyazawa T, Furuya T, Itagaki S, Tohya Y, Nakano K, Takahashi E, Mikami T (1989) Preliminary comparisons of the biological properties of two strains of feline immunodeficiency virus (FIV) isolated in Japan with FIV Petaluma strain isolated in the United States. Arch Virol 108: 59-68
18. Miyazawa T, Furuya T, Itagaki S, Tohya Y, Takahashi E, Mikami T (1989) Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch Virol 108: 131-135
19. Moore JP, Cao Y, Leu J, Qin L, Korber B, Ho DD (1996) Inter- and intraclade neutralization of human immunodeficiency virus type 1 : genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virol 70: 427-444
20. Olmsted RA, Barnes AK, Yamamoto JK, Hirsch VM, Purcell RH, Johnson PR (1989) Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci USA 86: 2 448-2452
21. Osborne R, Rigby M, Siebelink K, Neil JC, Jarrett O (1994) Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J Gen Virol 75: 3 641-3 645
22. Pecoraro MR, Miyazawa T, Oliva G, Nosseto E, Castellano MC, Tohya Y, Norimine J, Etcheverrigaray ME, Mikami T (1996) Aislamiento del virus de la immunodeficiencia felina en Argentina: descripción de las propiedades biologicas de las cepas aisladas en la ciudad de La Plata. Rev Med Vet 76: 438-444
23. Pecoraro MR, Tomonaga K, Miyazawa T, Kawaguchi Y, Sugita S, Tohya Y, Kai C, Etcheverrigaray ME, Mikami T (1996) Genetic diversity of Argentine isolates of feline immunodeficiency virus. J Gen Virol 77: 2 031-2 035
24. Pedersen NC, Ho EW, Brown ML, Yamamoto JK (1987) Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235: 790-793
25. Pu R, Okada S, Little ER, Xu B, Stoffs WV, Yamamoto JK (1995) Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies. AIDS 9: 235-242
26. Siebelink KHJ, Huisman W, Karkas JA, Rimmelzwaan GF, Bosch ML, Osterhaus ADME (1995) Neutralization of feline immunodeficiency virus by polyclonal feline antibodies: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J Virol 69: 5 124-5 127
27. Sodora DL, Shpaer EG, Kitchell BE, Dow SW, Hoover EA, Mullins JI (1994) Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol 68: 2230-2238
28. Weber J, Fenyö E-M, Beddows S, Kaleebu P, Bjöndal A, The WHO Network for HIV Isolation and Characterization (1996) Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. J Virol 70: 7 827-7 832
29. Yamamoto JK, Okuda T, Ackley CD, Louie H, Pembroke E, Zochlinski H, Munn RJ, Gardner MB (1991) Experimental vaccine protection against feline immunodeficiency virus. AIDS Res Hum Retroviruses 7: 911-922
30. Yamamoto JK, Hohdatsu T, Olmsted RA, Pu R, Louie H, Zochlinksi H, Acevedo V, Johnson HM, Soulds GA, Gardner MB (1993) Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol 67: 601-605